This blog is all about current FDA approved drugs to treat the hepatitis C virus (HCV) with a focus on treating HCV according to genotype, using information extracted from peer-reviewed journals, liver meetings/conferences, and interactive learning activities.
Risk Of Developing Liver Cancer After HCV Treatment
▼
Monday, May 5, 2014
Magnetic resonance elastography in compensated and decompensated cirrhosis
Magnetic resonance elastography in compensated and decompensated cirrhosis
Non-invasive predictors identifying subjects with compensated liver disease at highest risk for transitioning to a decompensated state are lacking. We hypothesized that liver shear stiffness as measured by magnetic resonance elastography is an important non-invasive predictor of hepatic decompensation. Dr. Sumeet Asrani discusses his article "Role of magnetic resonance elastography in compensated and decompensated liver disease"
http://bit.ly/1mg4DR0
What Is - Magnetic resonance elastography (MRE)
Researchers at Mayo Clinic have developed technology that uses sound waves to see if a patient's liver is harder than it should be — if it's developing fibrosis. It's called Magnetic Resonance Elastography (MRE), and it offers a noninvasive alternative to liver biopsy.
No comments:
Post a Comment